General Information

Database Accession: DI3000009

Name: TNF receptor associated factor 2 in complex with a peptide from OX40

PDB ID: 1d0a PDB

Experimental method: X-ray (2.00 Å)

Source organism: Homo sapiens

Proof of disorder: Inferred from motif

Primary publication of the structure:

Ye H, Park YC, Kreishman M, Kieff E, Wu H
The structural basis for the recognition of diverse receptor sequences by TRAF2.

(1999) Mol. Cell 4: 321-30

PMID: 10518213 PubMed

Abstract:

Many members of the tumor necrosis factor receptor (TNFR) superfamily initiate intracellular signaling by recruiting TNFR-associated factors (TRAFs) through their cytoplasmic tails. TRAFs apparently recognize highly diverse receptor sequences. Crystal structures of the TRAF domain of human TRAF2 in complex with peptides from the TNFR family members CD40, CD30, Ox40, 4-1BB, and the EBV oncoprotein LMP1 revealed a conserved binding mode. A major TRAF2-binding consensus sequence, (P/S/A/T)x(Q/E)E, and a minor consensus motif, PxQxxD, can be defined from the structural analysis, which encompass all known TRAF2-binding sequences. The structural information provides a template for the further dissection of receptor binding specificity of TRAF2 and for the understanding of the complexity of TRAF-mediated signal transduction.


Function and Biology Annotations from the GeneOntology database. Only terms that fit at least two of the interacting proteins are shown.

Molecular function: not assigned

Biological process:

tumor necrosis factor-mediated signaling pathway A series of molecular signals initiated by the binding of a tumor necrosis factor to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. GeneOntology

regulation of apoptotic process Any process that modulates the occurrence or rate of cell death by apoptotic process. GeneOntology

positive regulation of production of molecular mediator of immune response Any process that activates or increases the frequency, rate, or extent of the production of molecular mediator of immune response. GeneOntology

negative regulation of biological process Any process that stops, prevents, or reduces the frequency, rate or extent of a biological process. Biological processes are regulated by many means; examples include the control of gene expression, protein modification or interaction with a protein or substrate molecule. GeneOntology

positive regulation of lymphocyte activation Any process that activates or increases the frequency, rate or extent of lymphocyte activation. GeneOntology

regulation of immunoglobulin secretion Any process that modulates the frequency, rate or extent of the regulated release of immunoglobulins from a cell. GeneOntology

regulation of nucleic acid-templated transcription Any process that modulates the frequency, rate or extent of nucleic acid-templated transcription. GeneOntology

apoptotic signaling pathway A series of molecular signals which triggers the apoptotic death of a cell. The pathway starts with reception of a signal, and ends when the execution phase of apoptosis is triggered. GeneOntology

response to oxygen-containing compound Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an oxygen-containing compound stimulus. GeneOntology

Cellular component:

integral component of plasma membrane The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. GeneOntology

Structure Summary Structural annotations of the participating protein chains.

Entry contents: 4 distinct polypeptide molecules

Chains: G, A, B, C

Notes: Chains D, E, F, H, I, J, K and L were removed as chains A, B, C and G highlight the biologically relevant interaction.

Chain G

Name: Tumor necrosis factor receptor superfamily member 4 Disordered Inferred from motif

Source organism: Homo sapiens

Length: 6 residues

Sequence:Sequence according to PDB SEQRESTPIQEE

UniProtKB AC: P43489 (positions: 261-266) UniProt Coverage: 2.2%

UniRef90 AC: UniRef90_P43489 (positions: 261-266) UniRef90

Chain A

Name: TNF receptor-associated factor 2 Ordered component

Source organism: Homo sapiens

Length: 168 residues

Sequence:Sequence according to PDB SEQRESAMADLEQKVLEMEASTYDGVFIWKISDFPRKRQEAVAGRIPAIFSPAFYTSRYGYKMCLRIYLNGDGTGRGTHLSLFFVVMKGPNDALLRWPFNQKVTLMLLDQNNREHVIDAFRPDVTSSSFQRPVNDMNIASGCPLFCPVSKMEAKNSYVRDDAIFIKAIVDLTGL

UniProtKB AC: Q12933 (positions: 334-501) UniProt Coverage: 33.5%

UniRef90 AC: UniRef90_Q12933 (positions: 334-501) UniRef90

Chain B

Name: TNF receptor-associated factor 2 Ordered component

Source organism: Homo sapiens

Length: 168 residues

Sequence:Sequence according to PDB SEQRESAMADLEQKVLEMEASTYDGVFIWKISDFPRKRQEAVAGRIPAIFSPAFYTSRYGYKMCLRIYLNGDGTGRGTHLSLFFVVMKGPNDALLRWPFNQKVTLMLLDQNNREHVIDAFRPDVTSSSFQRPVNDMNIASGCPLFCPVSKMEAKNSYVRDDAIFIKAIVDLTGL

UniProtKB AC: Q12933 (positions: 334-501) UniProt Coverage: 33.5%

UniRef90 AC: UniRef90_Q12933 (positions: 334-501) UniRef90

Chain C

Name: TNF receptor-associated factor 2 Ordered component

Source organism: Homo sapiens

Length: 168 residues

Sequence:Sequence according to PDB SEQRESAMADLEQKVLEMEASTYDGVFIWKISDFPRKRQEAVAGRIPAIFSPAFYTSRYGYKMCLRIYLNGDGTGRGTHLSLFFVVMKGPNDALLRWPFNQKVTLMLLDQNNREHVIDAFRPDVTSSSFQRPVNDMNIASGCPLFCPVSKMEAKNSYVRDDAIFIKAIVDLTGL

UniProtKB AC: Q12933 (positions: 334-501) UniProt Coverage: 33.5%

UniRef90 AC: UniRef90_Q12933 (positions: 334-501) UniRef90

Evidence Evidence demonstrating that the participating proteins are unstructured prior to the interaction and their folding is coupled to binding.

Chain G: Disordered Inferred from motif

The protein region involved in the interaction contains a known functional linear motif (LIG_TRAF2_1).

Chain A: Ordered component

The MATH domain involved in the interaction is known to adopt a stable structure in isolation in trimeric form. A solved structure of the domain trimer without bound ligands is represented by PDB ID 1ca4.

Chain B: Ordered component

The MATH domain involved in the interaction is known to adopt a stable structure in isolation in trimeric form. A solved structure of the domain trimer without bound ligands is represented by PDB ID 1ca4.

Chain C: Ordered component

The MATH domain involved in the interaction is known to adopt a stable structure in isolation in trimeric form. A solved structure of the domain trimer without bound ligands is represented by PDB ID 1ca4.

Related Structure(s) Structures from the PDB that contain the same number of proteins, and the proteins from the two structures show a sufficient degree of pairwise similarity, i.e. they belong to the same UniRef90 cluster (the full proteins exhibit at least 90% sequence identity) and convey roughly the same region to their respective interactions (the two regions from the two proteins share a minimum of 70% overlap).

No related structure was found in the Protein Data Bank.




The molecule viewer shows our modified stucture.

The structure can be rotated by left click and hold anywhere on the structure. Representation options can be edited by right clicking on the structure window.

Download our modified structure (.pdb)

Download the original structure (.pdb)

Download this entry's XML file (.xml)